Founded in 1999 in Sweden, Genovis AB is a specialized life science tools company serving customers in the biopharmaceutical and research industries with technologies that simplify and accelerate the development of new treatment methods and diagnostics. Headquartered in Kävlinge, Sweden, the company is best known for its proprietary SmartEnzymes, which are used by scientists worldwide in research, analytical characterization, process development, and quality control of biological drugs. Genovis operates through Genovis AB and its wholly owned U.S. subsidiary, Genovis Inc., and is listed on Nasdaq First North Growth Market. In 2024, the company reported net sales of SEK 130.4 million and had 32 employees at year-end, reflecting a focused, scalable business model in advanced biopharmaceutical tools.
Updated 2026-03-19